Viewing data from:

LOXAPINE SUCCINATE

ANDA

LOXAPINE SUCCINATE | A076868 | ELITE LABORATORIES INC

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 4 NDCs

Highest NADAC/Unit

$0.9799

per ea

Lowest NADAC/Unit

$0.2979

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64850089301LOXAPINE 50 MG CAPSULE	$0.9799	EA	Generic	—	2026-08-19
64850089201LOXAPINE 25 MG CAPSULE	$0.6907	EA	Generic	—	2026-08-19
64850089101LOXAPINE 10 MG CAPSULE	$0.4592	EA	Generic	—	2026-08-19
64850089001LOXAPINE 5 MG CAPSULE	$0.2979	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs2 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

MEDICHEM SALOXAPINE SUCCINATE

DMF 67671986

CENTAUR PHARMACEUTICALS PRIVATE LTDLOXAPINE SUCCINATE USP

DMF 299772015

MIKAH PHARMA LLCInactiveLOXAPINE SUCCINATE

DMF 75771988

PROFARMACO SRLInactiveLOXAPINE SUCCINATE

DMF 88121990

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#001 — EQ 5MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Aug 4, 2005

No patent or exclusivity listings for this strength.

#002 — EQ 10MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Aug 4, 2005

#003 — EQ 25MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Aug 4, 2005

#004 — EQ 50MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Aug 4, 2005